Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03617445 · ClinicalTrials.gov registry record · Phase 2
Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT03617445 is a Phase 2 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 3 participants.
The verdict
NCT03617445, a Phase 2 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The objective is to examine the effect of Fecal Microbiota Transplantation (FMT) compared with vancomycin for cure of recurrent C. diff infection (CDI) in solid organ transplant (SOT) recipients in a randomized, controlled clinical trial.
Interventions
- DRUG Oral Vancomycin
- DRUG FMT oral capsule
- DRUG FMT oral placebo
- DRUG Oral Vancomycin placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-08-03 |
| Est. Completion | 2023-06-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03617445
The ClinicalTrials.gov registry entry for NCT03617445 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Oral Vancomycin is the first listed.
NCT03617445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03617445 about?
NCT03617445 is a clinical study titled "Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients". The objective is to examine the effect of Fecal Microbiota Transplantation (FMT) compared with vancomycin for cure of recurrent C. diff infection (CDI) in solid organ transplant (SOT) recipients in a randomized, controlled clinical trial.
What is the current status of trial NCT03617445?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2022-08-03. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT03617445?
The interventions under investigation include: Oral Vancomycin (DRUG), FMT oral capsule (DRUG), FMT oral placebo (DRUG), Oral Vancomycin placebo (DRUG).
Who is sponsoring clinical trial NCT03617445?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.